Acute Ischemic Stroke Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Bristol Myers Squib, Janssen, DiaMedica, Healios, Athersys, Athersys, GNT Pharma, NoNO Inc., Genentech

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 35+ key pharma and biotech companies are working on 35+ pipeline drugs in the Acute Ischemic Stroke therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Acute Ischemic Stroke Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Acute Ischemic Stroke Therapeutics Market.

The report provides a detailed description of the Acute Ischemic Stroke drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Acute Ischemic Stroke Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acute Ischemic Stroke Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Acute Ischemic Stroke therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Acute Ischemic Stroke treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Acute Ischemic Stroke drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Acute Ischemic Stroke treatment market.

Learn More about the Clinical and Commercial Development Activities in the Acute Ischemic Stroke Therapeutics Domain @
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acute Ischemic Stroke Therapeutics Analysis
Critical care specialists are important in the multidisciplinary approach used to treat Acute Ischemic Stroke. Antiplatelet medication is the mainstay of care for treating stroke and transient ischemic episodes. Due to its affordability, accessibility, and relative safety, aspirin is the most extensively used medication.

It is estimated that the Acute Ischemic Stroke treatment space will experience significant changes in the upcoming years, improved knowledge of stroke pathophysiology, awareness of symptoms, and developments in acute stroke care in the last two decades, a robust pipeline consisting of candidates with the potential to address the unmet need for Acute Ischemic Stroke patients and the various organizations focusing on research and development for novel therapies. However, delays in stroke assessment and treatment may lead to worse outcomes for a patient. A high degree of mortality and morbidity associated with ischemic stroke are two major factors likely to impede the market success of the upcoming.

Many molecules are in the pipeline to treat Acute Ischemic Stroke patients across many countries to cater to their needs. Some major late-stage products likely to hit the market during our study period 2019-2032 include MultiStem Cell Therapy (invimestrocel), Glenzocimab (ACT017), DM199, Nerinetide, and others.

The FDA has approved the standard gold therapy, tissue plasminogen activator, r-tPA, often known as alteplase, to treat ischemic stroke. Further, in November 2020, the US FDA approved BRILINTA to reduce the risk of stroke in patients with an acute ischemic stroke

There are approx. 35+ key Acute Ischemic Stroke companies which are developing Acute Ischemic Stroke therapies. Currently, GNT Pharma is leading the therapeutics market with its Acute Ischemic Stroke drug candidates in the most advanced stage of clinical development.

Acute Ischemic Stroke Companies in the Therapeutics Market Include:
AbbVie, Acticor Biotech, Angde Biotech Pharmaceutical, aptaTargets, Athersys|Healios K.K., Bayer, Biogen, Biogen Inc., Bristol-Myers Squibb, Clinuvel Pharmaceuticals, DiaMedica Therapeutics, Genentech, Inc., GNT Pharma, Healios, Janssen Pharmaceutical, JCR Pharmaceuticals, Lumosa Therapeutics, NC Medical Research, NoNO Inc., NuvOx Pharma, Pharmazz, Pharming Group, PT. Prodia Stem Cell Indonesia, Revalesio Corporation, Roche, Shin Poong Pharmaceutical, Shionogi & Co., Ltd., Silver Creek Pharmaceuticals, Supergene, Tasly Pharmaceutical, TrueBinding, Inc, ZZ Biotech, and others.

Emerging and Marketed Acute Ischemic Stroke Therapies Covered in the Report Include:
• BMS-986177/milvexian: Bristol Myers Squibb Company/Janssen
• DM199: DiaMedica Therapeutics
• Glenzocimab: Acticor Biotech
• Invimestrocel: Healios/Athersys
• LT3001: Lumosa Therapeutics
• Nelonemdaz: GNT Pharma
• Nerinetide: NoNO Inc.
• SP-8203: Shin Poong Pharmaceutical
• Tenecteplase: Genentech
And Many More

Get an in-depth Assessment of the Emerging Therapies and Acute Ischemic Stroke Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Acute Ischemic Stroke Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Acute Ischemic Stroke pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Acute Ischemic Stroke Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal

Molecule Type
Acute Ischemic Stroke Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule

Request for Sample PDF to Understand More About the Acute Ischemic Stroke Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Acute Ischemic Stroke Current Treatment Patterns
4. Acute Ischemic Stroke - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Acute Ischemic Stroke Late-Stage Products (Phase-III)
7. Acute Ischemic Stroke Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Acute Ischemic Stroke Discontinued Products
13. Acute Ischemic Stroke Product Profiles
14. Acute Ischemic Stroke Companies
15. Acute Ischemic Stroke Drugs
16. Dormant and Discontinued Products
17. Acute Ischemic Stroke Unmet Needs
18. Acute Ischemic Stroke Future Perspectives
19. Acute Ischemic Stroke Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Indolent Lymphoma Market
https://www.delveinsight.com/report-store/indolent-lymphoma-market

Lipodystrophy Market
https://www.delveinsight.com/report-store/lipodystrophy-market

Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market

Anaplastic Astrocytoma Market
https://www.delveinsight.com/report-store/anaplastic-astrocytoma-market

Singapore Healthcare Outlook
https://www.delveinsight.com/report-store/singapore-healthcare-outlook-report

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market
https://www.delveinsight.com/report-store/blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-market

Chronic Idiopathic Constipation Market
https://www.delveinsight.com/report-store/chronic-idiopathic-constipation-market

Hay Fever Conjunctivitis Market
https://www.delveinsight.com/report-store/hay-fever-conjunctivitis-market

Nasopharyngeal Carcinoma Market
https://www.delveinsight.com/report-store/nasopharyngeal-carcinoma-market

Cerebral Infarction Market
https://www.delveinsight.com/report-store/cerebral-infarction-market

CART-related Neurotoxicity (NT) Market
https://www.delveinsight.com/report-store/cart-related-neurotoxicity-nt-market

Hernia Repair Devices Market
https://www.delveinsight.com/report-store/hernia-repair-devices-market

Bronchial Hyperreactivity Market
https://www.delveinsight.com/report-store/bronchial-hyperreactivity-market

Chronic Focal Epilepsy Market
https://www.delveinsight.com/report-store/chronic-focal-epilepsy-market

Dental Lasers Market
https://www.delveinsight.com/report-store/dental-lasers-market

Down Syndrome Market
https://www.delveinsight.com/report-store/down-syndrome-market

Extracorporeal Circulation System Market
https://www.delveinsight.com/report-store/extracorporeal-circulation-system-market

Failed Back Surgery Syndrome Market
https://www.delveinsight.com/report-store/failed-back-surgery-syndrome-market

Germ Cell Tumor Market
https://www.delveinsight.com/report-store/germ-cell-tumor-market

Hot Flashes Market
https://www.delveinsight.com/report-store/hot-flashes-market

India Healthcare Outlook
https://www.delveinsight.com/report-store/india-healthcare-outlook-report

Insulin Glargine Biosimilar
https://www.delveinsight.com/report-store/insulin-glargine-biosimilar-insight

Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market

Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market

Mucopolysaccharidosis I Market
https://www.delveinsight.com/report-store/mucopolysaccharidosis-i-market

Nasolabial Fold Market
https://www.delveinsight.com/report-store/nasolabial-fold-market

Neuroleptic Malignant Syndrome Market
https://www.delveinsight.com/report-store/neuroleptic-malignant-syndrome-market

Pachyonychia Congenita Market
https://www.delveinsight.com/report-store/pachyonychia-congenita-market

Point of Care Glucose Testing Market
https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market

Reactive Airway Disease Market
https://www.delveinsight.com/report-store/reactive-airway-disease-market

Seborrhea Market
https://www.delveinsight.com/report-store/seborrhea-market

Substance (Drug) Abuse Market
https://www.delveinsight.com/report-store/substance-drug-abuse-market

Synchronous Endometrial and Ovarian Cancer (SEOC) Market
https://www.delveinsight.com/report-store/synchronous-endometrial-and-ovarian-cancer-seoc-market

Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight

Urinary Tract Infection Devices Market
https://www.delveinsight.com/report-store/urinary-tract-infection-devices-market

Varicose Veins Market
https://www.delveinsight.com/report-store/varicose-veins-market

Vulvodynia Market
https://www.delveinsight.com/report-store/vulvodynia-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.